Dr. Alexander M. Lesokhin

Dr. Alexander M. Lesokhin, MD, is an oncologist specializing in the treatment of multiple myeloma at Memorial Sloan Kettering Cancer Center. He is part of a dedicated team committed to delivering the highest-quality care for patients with this disease, including access to the newest treatment options through clinical trials. His clinical focus reflects a deep investment in advancing outcomes for people with multiple myeloma at a time when the rapid expansion of available therapies has opened promising new directions in the field.

Dr. Lesokhin's research centers on developing innovative immunotherapeutic approaches to cancer treatment. He leads clinical studies investigating medicines designed to enhance the immune response against cancer, alongside laboratory studies aimed at understanding how cancers like multiple myeloma evade immune detection. This dual approach, combining bench research with clinical investigation, positions his work at the forefront of efforts to uncover new strategies for treating patients with this disease.

Through his research and clinical practice, Dr. Lesokhin works to translate scientific discoveries into meaningful improvements in patient care. His commitment to understanding the relationship between cancer and the immune system drives both his laboratory investigations and his participation in clinical trials, with the shared goal of developing better, more effective treatments for people living with multiple myeloma.